We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
PHB2 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
320.1
Number of samples
349
Samples
Sample
Description
TPM
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
1029.9
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
1002.1
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
879.6
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
790.3
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
756.5
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
728.6
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
710.3
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
673.7
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
665.8
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
665.1
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
661.8
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
641.0
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
610.7
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
609.5
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
601.0
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
600.9
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
587.3
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
585.9
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
580.3
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
574.3
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
572.2
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
556.3
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
556.0
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
547.9
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
544.1
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
531.3
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
527.3
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
525.8
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
514.7
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
508.8
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
508.3
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
508.3
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
507.7
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
506.7
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
500.2
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
496.7
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
494.2
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
492.6
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
491.3
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
488.3
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
485.7
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
483.8
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
473.6
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
460.7
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
458.2
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
456.4
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
450.8
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
450.2
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
443.3
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
442.9
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
433.9
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
433.1
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
432.1
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
430.9
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
430.7
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
429.7
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
428.7
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
428.1
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
427.5
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
427.3
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
423.5
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
419.1
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
418.0
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
417.1
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
416.4
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
415.7
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
415.2
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
414.6
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
411.3
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
411.1
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
410.9
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
410.6
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
409.6
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
407.9
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
404.9
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
403.0
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
401.1
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
400.4
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
397.9
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
397.8
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
395.3
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
395.0
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
392.5
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
392.2
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
390.4
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
388.6
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
388.5
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
386.9
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
386.7
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
384.5
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
384.5
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
382.7
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
381.9
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
381.0
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
380.5
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
379.6
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
378.7
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
375.9
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
371.1
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
365.3
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
365.1
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
364.1
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
363.2
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
361.1
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
361.0
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
360.7
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
359.8
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
357.7
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
355.5
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
355.2
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
354.5
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
353.2
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
351.7
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
350.9
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
350.5
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
347.5
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
347.3
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
346.7
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
342.9
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
340.9
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
338.5
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
338.4
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
337.9
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
337.3
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
336.1
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
335.7
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
335.3
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
334.3
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
334.1
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
333.2
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
332.8
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
332.6
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
332.5
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
331.0
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
328.7
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
328.4
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
327.8
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
327.5
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
327.4
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
326.6
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
325.0
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
323.7
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
323.6
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
322.8
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
322.8
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
320.6
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
320.5
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
320.5
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
320.3
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
320.1
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
319.8
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
319.6
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
318.0
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
315.6
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
314.8
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
313.1
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
312.4
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
312.3
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
312.1
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
311.1
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
310.8
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
310.2
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
309.9
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
308.4
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
305.8
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
305.5
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
305.2
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
301.7
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
301.5
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
300.8
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
299.6
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
298.3
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
297.1
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
296.2
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
296.1
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
295.9
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
295.9
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
293.9
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
293.8
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
293.4
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
292.7
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
292.4
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
292.0
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
289.6
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
289.0
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
288.9
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
288.6
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
287.7
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
286.3
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
285.0
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
283.3
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
283.2
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
282.5
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
281.5
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
280.8
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
280.5
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
280.1
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
279.7
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
279.3
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
277.7
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
276.4
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
275.8
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
274.0
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
274.0
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
273.2
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
273.1
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
271.4
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
270.2
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
269.5
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
269.3
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
268.9
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
266.9
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
265.8
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
265.7
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
265.2
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
265.1
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
263.3
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
263.1
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
263.1
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
260.8
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
259.6
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
258.4
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
258.3
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
257.1
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
257.1
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
257.0
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
256.6
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
255.4
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
254.4
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
254.3
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
254.3
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
253.7
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
252.2
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
251.4
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
251.1
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
250.7
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
250.3
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
250.3
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
248.7
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
247.3
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
247.0
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
245.2
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
245.0
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
244.6
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
243.7
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
243.5
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
243.2
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
240.6
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
239.5
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
239.4
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
236.4
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
235.9
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
234.8
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
234.5
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
234.0
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
231.7
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
231.0
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
229.5
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
229.1
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
228.7
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
227.2
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
225.5
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
225.1
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
223.5
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
222.6
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
221.8
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
218.8
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
217.6
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
217.3
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
217.3
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
216.9
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
216.7
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
216.3
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
215.4
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
215.1
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
215.0
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
212.5
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
210.5
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
209.3
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
206.2
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
205.7
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
201.3
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
201.2
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
197.8
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
197.4
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
197.3
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
196.3
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
194.7
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
193.7
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
193.1
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
193.0
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
192.9
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
192.4
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
192.3
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
191.4
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
189.5
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
188.1
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
185.7
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
185.6
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
184.7
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
183.6
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
182.4
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
182.4
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
181.1
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
180.1
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
180.0
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
179.3
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
178.2
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
177.2
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
174.4
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
173.4
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
173.3
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
173.2
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
170.7
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
170.1
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
169.3
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
169.1
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
169.1
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
168.2
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
166.5
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
161.9
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
161.0
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
159.6
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
158.1
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
157.1
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
151.3
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
150.8
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
150.5
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
150.2
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
148.7
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
146.3
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
146.2
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
144.8
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
144.5
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
141.3
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
137.7
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
132.8
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
124.5
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
124.1
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
121.6
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
121.0
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
120.4
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
120.1
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
115.6
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
108.5
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
102.2
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
94.4
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
70.8
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
PHB2 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
235.2
Number of samples
81
Samples
Sample
Description
TPM
DO46338
0 years, female, NA, stage:III, dead, 596 days
474.1
DO46356
0 years, female, NA, stage:III, dead, 911 days
449.5
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
440.8
DO46362
0 years, female, NA, stage:III, dead, 1639 days
440.3
DO46370
0 years, female, NA, stage:III, dead, 1727 days
431.6
DO46538
0 years, female, NA, stage:III, dead, 1527 days
414.3
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
390.4
DO46468
0 years, female, NA, stage:III, alive, 2776 days
385.4
DO46518
0 years, female, NA, stage:III, alive, 2960 days
366.5
DO46352
0 years, female, NA, stage:III, dead, 677 days
353.9
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
340.5
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
322.9
DO46364
0 years, female, NA, stage:III, dead, 806 days
313.0
DO46331
0 years, female, NA, stage:III, dead, 612 days
312.0
DO46448
0 years, female, NA, stage:III, dead, 654 days
306.2
DO46358
0 years, female, NA, stage:III, dead, 423 days
304.8
DO46333
0 years, female, NA, stage:III, dead, 359 days
299.3
DO46581
0 years, female, NA, stage:III, dead, 408 days
289.6
DO46400
0 years, female, NA, stage:III, dead, 719 days
288.2
DO46533
0 years, female, NA, stage:III, alive, 3667 days
284.3
DO46342
0 years, female, NA, stage:III, dead, 1398 days
276.4
DO46586
0 years, female, NA, stage:III, dead, 1019 days
275.2
DO46493
0 years, female, NA, stage:IV, alive, 839 days
274.3
DO46576
0 years, female, NA, stage:III, alive, 133 days
267.3
DO46463
0 years, female, NA, stage:III, dead, 2451 days
264.2
DO46591
0 years, female, NA, stage:III, dead, 195 days
263.5
DO46390
0 years, female, NA, stage:III, dead, 374 days
263.0
DO46588
0 years, female, NA, stage:III, dead, 438 days
260.0
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
255.1
DO46334
0 years, female, NA, stage:III, dead, 496 days
253.4
DO46436
0 years, female, NA, stage:III, alive, 3193 days
249.5
DO46408
0 years, female, NA, stage:III, dead, 489 days
246.9
DO46366
0 years, female, NA, stage:III, dead, 2054 days
241.6
DO46378
0 years, female, NA, stage:III, alive, 843 days
241.2
DO46453
0 years, female, NA, stage:III, dead, 3294 days
237.6
DO46396
0 years, female, NA, stage:III, dead, 583 days
236.9
DO46443
0 years, female, NA, stage:III, dead, 2464 days
236.7
DO46602
0 years, female, NA, stage:III, dead, 205 days
233.4
DO46384
0 years, female, NA, stage:III, dead, 614 days
230.2
DO46329
0 years, female, NA, stage:III, dead, 1699 days
225.7
DO46325
0 years, female, NA, stage:III, dead, 477 days
222.8
DO46568
0 years, female, NA, stage:III, dead, 320 days
216.5
DO46332
0 years, female, NA, stage:III, dead, 689 days
215.7
DO46328
0 years, female, NA, stage:III, dead, 972 days
213.7
DO46354
0 years, female, NA, stage:III, dead, 843 days
207.4
DO46388
0 years, female, NA, stage:III, dead, 413 days
206.8
DO46386
0 years, female, NA, stage:III, dead, 1162 days
205.6
DO46566
0 years, female, NA, stage:III, dead, 673 days
202.4
DO46346
0 years, female, NA, stage:III, dead, 1187 days
200.2
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
196.9
DO46368
0 years, female, NA, stage:III, dead, 2879 days
196.1
DO46372
0 years, female, NA, stage:III, dead, 1326 days
195.5
DO46326
0 years, female, NA, stage:III, dead, 701 days
192.3
DO46546
0 years, female, NA, stage:III, dead, 1889 days
188.6
DO46432
0 years, female, NA, stage:III, alive, 2218 days
186.3
DO46561
0 years, female, NA, stage:III, dead, 195 days
182.3
DO46380
0 years, female, NA, stage:III, dead, 1423 days
180.9
DO46412
0 years, female, NA, stage:III, dead, 597 days
180.0
DO46330
0 years, female, NA, stage:III, dead, 684 days
178.9
DO46336
0 years, female, NA, stage:IV, dead, 664 days
173.5
DO46344
0 years, female, NA, stage:III, dead, 642 days
170.1
DO46392
0 years, female, NA, stage:III, dead, 628 days
169.6
DO46404
0 years, female, NA, stage:III, dead, 690 days
166.7
DO46597
0 years, female, NA, stage:III, dead, 393 days
165.1
DO46374
0 years, female, NA, stage:III, dead, 1409 days
164.4
DO46398
0 years, female, NA, stage:III, alive, 437 days
158.8
DO46376
0 years, female, NA, stage:III, dead, 1430 days
154.0
DO46508
0 years, female, NA, stage:III, dead, 2101 days
153.8
DO46340
0 years, female, NA, stage:III, dead, 616 days
151.6
DO46350
0 years, female, NA, stage:III, dead, 886 days
146.7
DO46571
0 years, female, NA, stage:III, dead, 243 days
141.6
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
138.0
DO46402
0 years, female, NA, stage:III, dead, 511 days
137.0
DO46560
0 years, female, NA, stage:IV, dead, 286 days
126.3
DO46327
0 years, female, NA, stage:III, dead, 184 days
117.8
DO46606
0 years, female, NA, stage:III, alive, 804 days
116.6
DO46348
0 years, female, NA, stage:IV, dead, 287 days
115.6
DO46528
0 years, female, NA, stage:III, alive, 6139 days
110.6
DO46382
0 years, female, NA, stage:IV, dead, 311 days
106.2
DO46551
0 years, female, NA, stage:III, dead, 1055 days
93.4
DO46611
0 years, female, NA, stage:III, dead, 734 days
68.6
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
1.3
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
1.2
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
1.1
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
1.1
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
1.0
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.9
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.9
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.8
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.8
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
0.8
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
0.7
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.7
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.7
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.6
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
0.6
2f901c90-617e-46da-9fac-d68369_D2
Tumor
0.5
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.5
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
0.5
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
0.5
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
0.5
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.5
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.5
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
0.5
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.5
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.5
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.5
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.5
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.5
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
0.5
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
0.5
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.5
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.5
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.5
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.4
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
0.4
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.4
a3a26070-fb84-406a-8280-d555e6_D2
Normal
0.4
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
0.4
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.4
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.4
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
0.4
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
0.3
1db5574d-aca7-403c-8100-6e705f_D2
Normal
0.3
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.3
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
0.3
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
0.3
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
0.3
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
0.3
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
0.3
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
0.3
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
0.3
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
0.2
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
0.2
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
0.2
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
0.2
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.2
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
0.2
15524912-685a-47ce-a824-567848_D2
Tumor
0.2
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
0.2
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.2
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
0.2
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.1
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
0.1
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.1
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.1
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
0.1
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
0.1
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
0.1
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
0.1
e9d416e7-f661-400a-896e-388545_D2
Tumor
0.1
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.1
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
0.1
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
0.1
a65d8e76-640f-4341-a561-afbb57_D2
Normal
0.1
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.0
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.0
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
0.0
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.0
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
0.0
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
0.0
21efd60f-6a31-4b98-9477-16a905_D2
Normal
0.0
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.0
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
0.0
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.0
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.0
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
0.0
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.0
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.0
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.0
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.0
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.0
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
-0.1
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.1
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.1
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
-0.1
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.1
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
-0.1
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-0.1
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.2
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
-0.2
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
-0.2
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-0.2
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.2
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
-0.2
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.3
10c2d629-0287-4511-ac25-f29031_D2
Tumor
-0.3
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.5
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-0.5
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.